Gujarat Themis Biosyn Ltd shares jump 6.86% as SEBI receives disclosure for Pharmaceutical Business Group India Ltd & Others
Why did Gujarat Themis Biosyn Ltd shares jump today?
Gujarat Themis Biosyn Ltd shares saw a significant jump of 6.86% on Monday, reaching ₹440.0 per share at 11:16 AM. The sharp rise in the stock price is directly linked to a corporate announcement made by the company to the stock exchanges.
The company filed a disclosure under SEBI's takeover regulations. The key detail from the news is that the promoters and promoter group of Gujarat Themis Biosyn have actually bought any new shares. Instead, their overall percentage of ownership in the company passively decreased. This happened because the company recently issued 2,11,86,440 new equity shares to non-promoter qualified institutional buyers (QIBs) on August 28, 2026, as part of a Qualified Institutional Placement (QIP).
This QIP is the core event. Essentially, the company raised fresh capital by selling new shares to large institutional investors. While this dilutes the existing promoters' percentage stake, it infuses growth capital into the business. The market's positive reaction—a nearly 7% jump—suggests investors view this as a favorable move, likely expecting the raised funds to be used for business expansion, debt reduction, or other growth initiatives.
What does Gujarat Themis Biosyn Ltd do?
Gujarat Themis Biosyn Limited is based in the GIDC Industrial Estate in Vapi, Gujarat. The company communicates through its corporate office, with contact information including a physical address in Mumbai and an email for CFO-related assistance.
The company has issued a formal disclosure under SEBI regulations regarding the shareholding of its Promoters and Promoter Group. This disclosure informs stock exchanges that the Promoters and Promoter Group have not acquired any shares or voting rights in the company, and notes that any change in their shareholding percentage is a passive reduction.
Gujarat Themis Biosyn Ltd Financials
In CroresGujarat Themis Biosyn Ltd's revenue slightly declined from ₹44.23 Crores in March 2026 to ₹43.79 Crores in June 2026, representing a marginal decrease of approximately 1%. Conversely, the company's profit grew modestly from ₹10.89 Crores to ₹11.07 Crores over the same period, an increase of about 1.65%. This indicates an inverse trend where the company managed to improve its profitability despite a minor dip in top-line revenue.
Gujarat Themis Biosyn Ltd Shareholding Pattern
Promoter holding stands at 70.87% of the total share capital. Foreign Institutional Investors (FIIs) hold 1.76% stake in the company, while Domestic Institutional Investors (DIIs) hold 1.17%. Public shareholders hold the remaining 26.18% stake in Gujarat Themis Biosyn Ltd.
Gujarat Themis Biosyn Ltd FAQs
Q: Why did Gujarat shares jump 6.86% today?
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Pharmaceutical Business Group India Ltd & Others. This corporate action caught investor attention, leading to increased trading activity in the stock.
Q: What is the shareholding pattern of Gujarat Themis Biosyn Ltd?
As per the latest data, promoters hold 70.87% stake in Gujarat Themis Biosyn Ltd, while FII holding stands at 1.76%. Domestic institutional investors hold 1.17%, and public shareholders account for 26.18% of the equity.
Q: What is the current stock price of Gujarat Themis Biosyn Ltd?
Gujarat Themis Biosyn Ltd shares are currently trading at ₹440.0, recording a gain of 6.86% from the previous close.
Q: What is the market capitalization of Gujarat Themis Biosyn Ltd?
The company currently has a market capitalization of ₹5726.68 crore, reflecting its valuation in the Indian equity market.